cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Abeona Therapeutics Inc
112 own
128 watching
Current Price
$2.52
$0
(0%)
logo-abeo
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
19.33M
52-Week High
52-Week High
9.355
52-Week Low
52-Week Low
2.34
Average Volume
Average Volume
0.2M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization19.33M
icon52-Week High9.355
icon52-Week Low2.34
iconAverage Volume0.2M
iconDividend Yield--
iconP/E Ratio--
What does the Abeona Therapeutics Inc do?
Abeona Therapeutics Inc., a biopharmaceutical company, focuses on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases. The company offers MuGard, a mucoadhesive oral wound rinse for mucositis, stomatitis, aphthous ulcers, and traumatic ulcers; and ProctiGard, a mucoadhesive oral wound rinse for the treatment of rectal mucositis and radiation proctitis. Its lead program is an adeno-associated virus (AAV)-based gene therapy for sanfilippo syndrome. The company develops ABO-101 for Mucopolysaccharidosis (MPS) III, a sanfilippo syndrome Type B; ABO-102 for MPS III, a sanfilippo syndrome Type A; ABO-201 for juvenile batten disease; ABO-301 for fanconi anemia; and clustered, regularly interspaced short palindromic repeats (CRISPR)-CRISPR associated protein 9 AAV for rare blood diseases. It also develops PTB-101 salt diafiltration process (SDF) Alpha, a alpha1-proteinase inhibitor for chronic augmentation and maintenance therapy in adults with clinically evident emphysema due to severe deficiency of alpha1-proteinase inhibitor; and PTB-102 SDF IVIG, an intravenous immunoglobulin for autoimmune, infectious, and idiopathic diseases. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was incorporated in 1989 and is based in Dallas, Texas.
Read More
How much money does Abeona Therapeutics Inc make?
News & Events about Abeona Therapeutics Inc.
Globe Newswire
8 months ago
Disposition of MPS programs to reduce operating expenses andextend projected cash runway into 2Q 2023 Focus R&D resources on EB-101 pivotal phase 3 VIITAL topline data expected in 3Q 2022 NEW YORK and CLEVELAND, May 13, 2022 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-...
Globe Newswire
9 months ago
NEW YORK and CLEVELAND, April 29, 2022 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in cell and gene therapy, today announced that preclinical data on AAV204, a novel adeno-associated virus (AAV) capsid from Abeonas in-licensed AIM capsid library, will be ...
Globe Newswire
9 months ago
NEW YORK and CLEVELAND, April 29, 2022 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in cell and gene therapy, today announced that it has entered into a securities purchase agreement with certain institutional investors to purchase 1,000,006 shares of Series...
Globe Newswire
10 months ago
NEW YORK and CLEVELAND, March 28, 2022 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that Vish Seshadri, Ph.D., Chief Executive Officer of Abeona Therapeutics, will participate in a panel discussion titled, Cell ...
Frequently Asked Questions
Frequently Asked Questions
What is Abeona Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Abeona Therapeutics Inc shares?
plus_minus_icon
How can I buy Abeona Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Abeona Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Abeona Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Abeona Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Abeona Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Abeona Therapeutics Inc?
plus_minus_icon
What percentage is Abeona Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Abeona Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$2.52
$0
(0%)
logo-abeo
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00